Loading
Total declarations
Companies
▲ Purchases (55 ops.)
▼ Sales (20 ops.)
Latest filing published 16 Jul 2026 for XOMA Royalty Corp. Read the official filing
Filing timeline
BuySaleBVF Partners L P/il
Insider track record
Disclosed buys
55
Disclosed sells
20
T+90 hit rate
67%
T+90 mean return
+15.2%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
BVF Partners L P/il: trading record in brief
BVF Partners L P/il discloses dealings in 18 companies, chiefly Kymera Therapeutics, Inc., XOMA Royalty Corp and CTI Biopharma Corp. In total, 97 filings cover trades dated from 7 January 2016 to 14 July 2026.
The open-market side counts 55 purchases for €117.5M alongside 20 sales for €329.2M. The totals do not cover 14 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. 2026 to date brings no purchases and 7 sales.
In size, the median ticket on the buying side is €1.6M. Clusters matter here: 2 out of 55 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 16 July 2026 came the latest disclosure, a transaction in XOMA Royalty Corp. The most recent open-market purchase was published on 1 July 2025, 474 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to BVF Partners L P/il
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations97 total
3,635,758 sharesCommon Stock, $0.0075 par value per shareSEC:0000921895-26-001823:0
2,773,545 sharesCommon Stock, $0.0075 par value per shareSEC:0000921895-26-001823:1
412,000 sharesCommon Stock, $0.0075 par value per shareSEC:0000921895-26-001823:2
772,000 sharesCommon Stock, $0.0075 par value per shareSEC:0000921895-26-001823:3
837,914 sharesCommon Stock, $0.0001 par valueSEC:0000921895-26-001688:0
627,597 sharesCommon Stock, $0.0001 par valueSEC:0000921895-26-001688:1
113,289 sharesCommon Stock, $0.0001 par valueSEC:0000921895-26-001688:2
51,858 sharesCommon Stock, $0.0001 par valueSEC:0000921895-26-001688:3
1,932,354 shares@ US$16.7919.3% of flowClass A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:0
1,569,116 shares@ US$16.7915.7% of flowClass A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:1
248,530 shares@ US$16.792.5% of flowClass A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:2
5,309,432 sharesCommon Shares, no par valueSEC:0000921895-26-000173:0
6,194,145 sharesCommon StockSEC:0000921895-25-002742:0
4,726,743 sharesCommon StockSEC:0000921895-25-002742:1
560,797 sharesCommon StockSEC:0000921895-25-002742:2
1,481,634 shares100.0% of flowCommon StockSEC:0000921895-25-002133:0
142,604 shares@ US$44.0010.8% of flowCommon Stock, $0.0001 par valueSEC:0000921895-25-001910:0
Canonical exit: 28 Sept 2025 (T+90)
115,783 shares@ US$44.008.7% of flowCommon Stock, $0.0001 par valueSEC:0000921895-25-001910:1
Canonical exit: 28 Sept 2025 (T+90)
58,780 shares@ US$44.004.4% of flowCommon Stock, $0.0001 par valueSEC:0000921895-25-001910:2
Canonical exit: 28 Sept 2025 (T+90)
657,308 sharesCommon StockSEC:0000921895-25-001784:0
127,407 shares@ US$27.1015.9% of flowCommon Stock, $0.0075 par value per shareSEC:0000921895-25-001602:0
8,679,726 sharesCommon Stock, $0.001 par valueSEC:0000921895-25-001590:0
339,679 shares@ US$26.1043.9% of flowCommon Stock, $0.0075 par value per shareSEC:0000921895-25-000177:0
85,776 shares@ US$26.1011.1% of flowCommon Stock, $0.0075 par value per shareSEC:0000921895-25-000177:1
75,287 shares@ US$26.109.7% of flowCommon Stock, $0.0075 par value per shareSEC:0000921895-25-000177:2
25 of 97 declarations
